Targeted News Service logo

-- Preview Email Newsletter
News Tipoffs - New Hampshire Editors Newsletter for 2026-10-13 ( 5 items )  
Census Bureau Issues Working Paper Entitled 'State Tax Liability & Post-Tax Income Estimates by State' (10)
WASHINGTON, Oct. 11 (TNSLrpt) -- The U.S. Census Bureau issued the issued the following working paper paper (No. 2026-19) in September 2026 entitled "State Tax Liability and Post-Tax Income Estimates by State using the Current Population Survey Annual Social and Economic Supplement Tax Model." The paper was written by Kathryn Shantz and Elizabeth Pelletier. Here are excerpts: * * * Abstract State and federal tax policies have a substantial effect on the economic wellbeing of U.S. households. Taxes owed and tax credits received vary widely  more PR

Federal Register: FDA Finalizes Guidance on Postapproval Manufacturing Changes for Biosimilar Products (10)
WASHINGTON, Oct. 10 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register. * * * Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers; Guidance for Industry; Availability The Food and Drug Administration (FDA) is announcing the availability of a final guidance for industry entitled "Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers." Thi more PR

Federal Register: FDA Finds Discontinued Lasix Oral Solution Safe, Paving Way for Generic Approval (10)
WASHINGTON, Oct. 10 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register. * * * Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness The Food and Drug Administration (FDA) has determined that LASIX oral solution, 10 milligrams (mg)/milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin  more PR

Reproductive Freedom for All Launches "My Body. My Ballot." Campaign Tour Across Battleground States in October (10)
WASHINGTON, Oct. 12 [Category: Political] -- Reproductive Freedom for All (formerly the NARAL Pro-Choice America) posted the following news release: * * * Reproductive Freedom for All Launches "My Body. My Ballot." Campaign Tour Across Battleground States in October * Washington, DC -- With less than a month until Election Day, Reproductive Freedom for All is taking our historic My Body. My Ballot. midterm campaign on the road across key battleground states. Reproductive Freedom for All President and CEO Mini Timmaraju kicks off the tour in more PR

Trustee JoAnn Franke Overfield '69 Brings Reichhold Sculpture Back to Campus (10)
NEW LONDON, New Hampshire, Oct. 12 -- Colby-Sawyer College posted the following news: * * * Trustee JoAnn Franke Overfield '69 Brings Reichhold Sculpture Back to Campus * The Colby-Sawyer campus will soon be richer with three-dimensional visual art, thanks to Board of Trustees member JoAnn Franke Overfield '69. Overfield is heading an initiative to install a sculpture by artist Robert Friedman (1929-2019) on the exterior of the Davidow Center for Art + Design. The sculpture was previously displayed on the exterior of the Reichhold Science C more PR